Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings?

Overview of attention for article published in Pharmaceutical Medicine, January 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Readers on

mendeley: 35 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 10,333 followers.

RT @StanMehr: See our latest contribution to the literature on the state of US market access to #biosimilars. https://t.co/OoUfHTXul3 .

19 Feb 2019

Reply Repost Favourite

See our latest contribution to the literature on the state of US market access to #biosimilars. https://t.co/OoUfHTXul3 .

19 Feb 2019

Reply Repost Favourite

I've just published a new article with my co-author Rich Brook: #Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings?" https://t.co/OoUfHTXul3

17 Jan 2019

Reply Repost Favourite